
Interleukin-23: a key cytokine in inflammatory diseases
Interleukin-23 (IL-23) is a pro-inflammatory cytokine composed of two subunits, p19 and p40. The p40 subunit is shared with IL-12. IL-23 and IL-12 have different receptors and different effects.
What is IL-23? - Johnson & Johnson
Apr 29, 2024 · IL-23 controls immune cells. Learn how IL-23 is the target of potential Johnson & Johnson medications that could treat psoriasis, IBD and rheumatoid arthritis.
Interleukin-23 in perspective - PMC - PubMed Central (PMC)
IL-23 acts locally in tissues by activating IL-23R + cells. IL-23 is a coordinating cytokine in psoriasis, psoriatic arthritis and inflammatory bowel disease. IL-23 history. IL-23 was …
Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic ...
Recent studies have demonstrated the crucial role of IL-23 in the regulation of Th1 cell responses and its potential role in the CD pathogenesis. IL-23 belongs to the IL-12 family, it is composed …
The regulatory mechanism and potential application of IL-23 in ...
Regulatory mechanism of IL-23 in autoimmune diseases. IL-23 is involved in immune mediation by activating signaling pathways such as JaK-STAT, PI3K/Akt and NF-κB, thereby promoting …
Interleukin 23 - an overview | ScienceDirect Topics
Interleukin (IL-)23 is a central cytokine controlling T H 17 development. • Overshooting IL-23 signaling contribute to autoimmune diseases. • IL-23 is a member of the IL-12-type cytokine …
IL-23 past, present, and future: a roadmap to advancing IL-23 …
Apr 15, 2024 · Interleukin (IL)-23, an IL-12 cytokine family member, is a hierarchically dominant regulatory cytokine in a cluster of immune-mediated inflammatory diseases (IMIDs), including …
Anti–Interleukin-23 Autoantibodies in Adult-Onset …
Mar 20, 2024 · Nur S, Sparber F, Lemberg C, et al. IL-23 supports host defense against systemic Candida albicans infection by ensuring myeloid cell survival. PLoS Pathog …
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
Feb 22, 2021 · The central contribution of IL-23/IL-17 axis in both PsA and psoriasis is confirmed by the efficacy of biologics neutralizing IL-17 or IL-23/IL-12 as well as the effectiveness of TNF …
IL-23 Inhibitors: Breakthroughs in Modern Immunotherapy
Mar 12, 2025 · IL-23 inhibitors have transformed treatment for conditions like psoriasis and inflammatory bowel disease by selectively blocking key inflammatory signals. These inhibitors …